Cargando…

Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine

: a predictor of ageing and related pathologies, a sensor of lifestyle quality and progression of suboptimal health conditions to diseases for their targeted prevention; and as a potent target for cost-effective treatments tailored to the person.

Detalles Bibliográficos
Autores principales:	Torres Crigna, Adriana, Link, Barbara, Samec, Marek, Giordano, Frank A., Kubatka, Peter, Golubnitschaja, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334338/ https://www.ncbi.nlm.nih.gov/pubmed/34367381 http://dx.doi.org/10.1007/s13167-021-00248-z

Ejemplares similares

Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
por: Crigna, Adriana Torres, et al.
Publicado: (2020)

Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care
por: Mazurakova, Alena, et al.
Publicado: (2022)

Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2022)

Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?
por: Link, Barbara, et al.
Publicado: (2021)

Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
por: Liskova, Alena, et al.
Publicado: (2021)

General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2012)

Editorial Letter: Promoting Predictive, Preventive and Personalised Medicine in global scale
por: Golubnitschaja, Olga
Publicado: (2010)

Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine
por: Richter, Kneginja, et al.
Publicado: (2021)

Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management
por: Liskova, Alena, et al.
Publicado: (2020)

Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism
por: Samec, Marek, et al.
Publicado: (2020)

Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine
por: Kubatka, Peter, et al.
Publicado: (2022)

European strategies in predictive, preventive and personalised medicine: highlights of the EPMA World Congress 2011
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Promoting predictive, preventive and personalised medicine in global scale: the EPMA World Congress 2011
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Promoting predictive, preventive and personalised medicine: European event of global importance
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

The EPMA Journal introduces a new type of research article dedicated to predictive, preventive and personalised medicine
por: Golubnitschaja, Olga
Publicado: (2013)

Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine
por: Lučanský, Vincent, et al.
Publicado: (2023)

Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management—Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2023)

Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, preventive and personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2018)

Paradigm change to cost-effective predictive and preventive medicine: individual profiling of healthy vasospastic individuals for targeted prevention as the cost-effective personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Coincidence of cardiovascular disease and breast cancer in females: Multi-modal strategies by predictive, preventive and personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs
por: Yeghiazaryan, Kristina, et al.
Publicado: (2010)

Wrist actigraphic approach in primary, secondary and tertiary care based on the principles of predictive, preventive and personalised (3P) medicine
por: Acker, Jens, et al.
Publicado: (2021)

Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person
por: Koklesova, Lenka, et al.
Publicado: (2021)

Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper
por: Golubnitschaja, Olga, et al.
Publicado: (2022)

10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020
por: Golubnitschaja, Olga, et al.
Publicado: (2020)

Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine
por: Koklesova, Lenka, et al.
Publicado: (2021)

Time for new guidelines in personalised healthcare: PPPM related legislation
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare
por: Zubor, Pavol, et al.
Publicado: (2020)

Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine
por: Koklesova, Lenka, et al.
Publicado: (2020)

Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention
por: Koklesova, Lenka, et al.
Publicado: (2021)

Carotenoids in Cancer Apoptosis—The Road from Bench to Bedside and Back
por: Koklesova, Lenka, et al.
Publicado: (2020)

Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine
por: Kapinova, Andrea, et al.
Publicado: (2023)

Education in predictive, preventive and personalised medicine
Publicado: (2011)

Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects—the evidence-based 3PM proposition to mitigate individual risks
por: Liskova, Alena, et al.
Publicado: (2021)

Personalised medicine in asthma: from curative to preventive medicine
por: Guilleminault, Laurent, et al.
Publicado: (2017)

Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
por: Golubnitschaja, Olga, et al.
Publicado: (2013)

Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments
por: Yeghiazaryan, Kristina, et al.
Publicado: (2011)

Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways
por: Kubatka, Peter, et al.
Publicado: (2021)

Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
por: Mazurakova, Alena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tect29uoq0kckbg8ca7g42t3if